Mahmoud Mattia A, Ehsan Sarah, Ginzberg Sara P, Domchek Susan M, Nathanson Katherine L, Conant Emily F, Kontos Despina, Chen Jinbo, Edmonds Christine E, Fayanju Oluwadamilola M, McCarthy Anne Marie
Department of Biostatistics, Epidemiology, & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
JAMA Netw Open. 2025 Aug 1;8(8):e2525216. doi: 10.1001/jamanetworkopen.2025.25216.
Women with dense breasts have elevated risk of false-negative mammograms and may benefit from supplemental screening.
To assess potential outcomes of Pennsylvania's law mandating insurance coverage for supplemental breast cancer screening among Black and White women.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included Black and White women, aged 40 to 74 years, without prior breast cancer or known BRCA1/2 variants who underwent mammography screening at a large urban academic health system from January 2015 to December 2021, with cancer outcomes ascertained through December 2022. Data analysis was conducted from June 2023 to April 2025.
Dense breasts; the law mandates insurance coverage for women with extremely dense breasts or those with heterogeneously dense breasts plus a greater than 20% lifetime breast cancer risk by risk models.
The main outcomes were odds of eligibility for supplemental coverage and of a false-negative mammogram.
A total of 68 478 women (38 397 Black women [median (IQR) age, 57 (49-64) years] and 30 081 White women [median (IQR) age, 58 (49-65) years]) were used for the analysis. Fewer Black women had extremely dense breasts (561 [2.1%] vs 1464 [5.8%]; P = .02) and greater than 20% lifetime risk of breast cancer identified (257 [0.7%] vs 1905 [6.4%]; P = .04) compared with White women. Consequently, Black women were less likely to meet the eligibility criteria for supplemental screening (523 [1.6%] vs 2081 [8.4%]; P = .02). The criteria showed lower sensitivity but higher specificity for detecting false-negative mammograms in Black compared with White women in one round of screening. Using heterogeneously or extremely dense breasts alone would detect more false negatives but with significantly more women recommended for magnetic resonance imaging.
In this study of 68 478 screening mammograms among Black and White women from 2015 to 2021, retrospectively applying criteria for supplemental screening based on heterogeneously or extremely dense breast density and lifetime risk had limited ability to identify women at risk for a false-negative mammogram. Given lower density and lifetime risk estimates, few Black women met criteria for insurance coverage in Pennsylvania, and the criteria had poor sensitivity for identifying Black women with false-negative mammograms. Additionally, using the current breast density criteria for magnetic resonance imaging may not accurately reflect breast cancer risk in Black women.
乳房致密的女性乳房X光检查出现假阴性结果的风险升高,补充筛查可能对其有益。
评估宾夕法尼亚州要求为黑人和白人女性的补充乳腺癌筛查提供保险覆盖的法律可能产生的结果。
设计、地点和参与者:这项横断面研究纳入了年龄在40至74岁之间、无既往乳腺癌或已知BRCA1/2基因变异的黑人和白人女性,她们于2015年1月至2021年12月在一个大型城市学术医疗系统接受了乳房X光筛查,癌症结局随访至2022年12月。数据分析于2023年6月至2025年4月进行。
乳房致密;该法律规定为乳房极度致密或乳房密度不均匀且根据风险模型终生患乳腺癌风险大于20%的女性提供保险覆盖。
主要结局是符合补充筛查条件的几率以及乳房X光检查假阴性的几率。
共有68478名女性(38397名黑人女性[年龄中位数(四分位间距),57(49 - 64)岁]和30081名白人女性[年龄中位数(四分位间距),58(49 - 65)岁])纳入分析。与白人女性相比,有极度致密乳房的黑人女性较少(561例[2.1%]对1464例[5.8%];P = 0.02),且确定终生患乳腺癌风险大于20%的黑人女性也较少(257例[0.7%]对1905例[6.4%];P = 0.04)。因此,黑人女性符合补充筛查资格标准的可能性较小(523例[1.6%]对2081例[8.4%];P = 0.02)。在一轮筛查中,该标准在检测黑人女性乳房X光检查假阴性方面的敏感性低于白人女性,但特异性更高。仅使用乳房密度不均匀或极度致密来检测会发现更多假阴性,但推荐进行磁共振成像检查的女性显著增多。
在这项对2015年至2021年期间68478例黑人和白人女性乳房X光筛查的研究中,基于乳房密度不均匀或极度致密以及终生风险对补充筛查标准进行回顾性应用,识别乳房X光检查假阴性风险女性的能力有限。鉴于较低的乳房密度和终生风险估计值,很少有黑人女性符合宾夕法尼亚州的保险覆盖标准,且该标准在识别有乳房X光检查假阴性的黑人女性方面敏感性较差。此外,使用当前的乳房密度标准进行磁共振成像检查可能无法准确反映黑人女性的乳腺癌风险。